IP Library Granted Patent US 12,083,244
Granted Patent B2
US 12,083,244 · App. 15/267,026 · Granted Sep 10, 2024

Cross-linked dehydrated placental tissue grafts and methods for making and using the same

Inventors: Tom Koob (Marietta, GA); John Daniel (Marietta, GA); Randall Spencer (Marietta, GA)
Assignee: MiMedx Group, Inc.
A61L27/3604A61K35/50A61L15/40A61L27/3687A61L27/50A61L27/54A61L27/60A61L2430/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,083,244
App. No.
15/267,026
Granted
Sep 10, 2024
Kind
B2
Abstract

Described herein are tissue grafts produced by contacting dehydrated placental tissue grafts with a cross-linking agent. The tissue grafts described herein provide barrier and prevent the migration of a bioactive agent from the wound. Thus, the tissue grafts enhance wound healing while preventing the undesirable migration of a bioactive agent from the wound. Methods for making and using the cross-linked grafts are also described herein.

Claims (27)

1. A method for producing a dehydrated, cross-linked placental tissue graft, the method consisting of

i) contacting a dehydrated placental tissue graft with a solution comprising a cross-linking agent, thereby forming a cross-linked placental tissue graft; and

ii) dehydrating the cross-linked placental tissue graft formed in step 1), thereby forming the dehydrated, cross-linked placental tissue graft;

wherein the dehydrated placental tissue graft comprises at least two layers of amnion, or at least one layer of each of chorion and amnion; and

wherein at least one amnion layer comprises an amniotic fibroblast cell layer.

2. A method for enhancing wound healing in a subject comprising applying a tissue graft produced according to the method of claim 1 to the wound.

3. A method for reducing scar formation on or near the spine after a surgical procedure, the method comprising applying to a subject a tissue graft produced according to the method of claim 1 directly to the spinal dura of the subject, or a region near the spine.

4. The method of claim 3 , wherein the surgical procedure comprises a posterior procedure.

5. The method of claim 4 , wherein the posterior procedure is a laminectomy or discectomy.

6. The method of claim 3 , wherein the surgical procedure comprises an anterior procedure.

7. The method of claim 6 , wherein the anterior procedure is an Anterior Lumbar Interbody Fusion (ALIF) or Transforaminal Lumbar Interbody Fusion (TLIF).

8. A method for treating a dural tear in a subject, the method comprising applying directly to the dural tear a tissue graft produced according to the method of claim 1 .

9. The method of claim 2 , wherein the tissue graft comprises one or more additional placental components.

10. The method of claim 9 , wherein the one or more additional placental components comprise amnion, amnion membrane, chorion, Wharton's jelly, or any combination thereof.

11. The method of claim 2 , wherein the placental tissue graft comprises a laminate of amnion and chorion.

12. The method of claim 2 , wherein the placental tissue graft comprises a plurality of chorion and/or amnion membranes laminated to one another.

13. The method of claim 2 , wherein the dehydrated placental tissue graft was chemically dehydrated or thermally dehydrated.

14. The method of claim 2 , wherein the cross-linking agent comprises a sugar, a dialdehyde, an epoxide, a hydrazide, or a carbodiimide.

15. The method of claim 14 , wherein the sugar comprises D-ribose, glycerose, altrose, talose, ertheose, glucose, lyxose, mannose, xylose, gulose, arabinose, idose, allose, galactose, maltose, lactose, sucrose, cellibiose, gentibiose, melibiose, turanose, trehalose, isomaltose, or any combination thereof.

16. The method of claim 3 , wherein the tissue graft comprises one or more additional placental components.

17. The method of claim 16 , wherein the one or more additional placental components comprise amnion, amnion membrane, chorion, Wharton's jelly, or any combination thereof.

18. The method of claim 3 , wherein the placental tissue graft comprises a laminate of amnion and chorion.

19. The method of claim 3 , wherein the placental tissue graft comprises a plurality of chorion and/or amnion membranes laminated to one another.

20. The method of claim 3 , wherein the cross-linking agent comprises a sugar, a dialdehyde, an epoxide, a hydrazide, or a carbodiimide.

21. The method of claim 20 , wherein the sugar comprises D-ribose, glycerose, altrose, talose, ertheose, glucose, lyxose, mannose, xylose, gulose, arabinose, idose, allose, galactose, maltose, lactose, sucrose, cellibiose, gentibiose, melibiose, turanose, trehalose, isomaltose, or any combination thereof.

22. The method of claim 1 , wherein the placental tissue graft comprises at least one layer of each of chorion and amnion.

23. The method of claim 1 , wherein the dehydrated, cross-linked placental tissue graft is opaque.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2024
From: HAYFIN SERVICES LLP
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 066493/0322 →
SECURITY INTEREST Recorded Jan 25, 2024
From: MIMEDX GROUP, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 066371/0136 →
PATENT SECURITY AGREEMENT Recorded Jul 2, 2020
From: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 053121/0833 →
RELEASE OF SECURITY INTEREST Recorded Jul 2, 2020
From: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 054075/0687 →
SECURITY INTEREST Recorded Jun 11, 2019
From: MIMEDX GROUP, INC.
To: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 049426/0863 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2016
From: KOOB, TOM; DANIEL, JOHN; SPENCER, RANDALL
To: MIMEDX GROUP, INC.
Reel/Frame 039768/0590 →
Continuity (3)
Division 13719150 · Dec 18, 2012
Provisional Application 61579206 · Dec 22, 2011
Related Publication 20170000927A1 · Jan 5, 2017